Is Russia’s cancer vaccine ready for use?

Scientists in Russia have developed an mRNA-based cancer vaccine, which has reportedly shown 100 per cent efficacy during clinical trials. The vaccine, called Enteromix, now reportedly awaits final approval from the Ministry of Health before being available to the public

Explainers